104P Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib

Autor: Garcia-Foncillas, J., Bokemeyer, C., Italiano, A., Keating, K., Paracha, N., Fellous, M., Marian, M., Fillbrunn, M., Gao, W., Ayyagari, R., Lassen, U.N.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S401-S401
Databáze: ScienceDirect